293 related articles for article (PubMed ID: 35603208)
1. Cytokine-Induced Memory-Like NK Cells: From the Basics to Clinical Applications.
Terrén I; Orrantia A; Astarloa-Pando G; Amarilla-Irusta A; Zenarruzabeitia O; Borrego F
Front Immunol; 2022; 13():884648. PubMed ID: 35603208
[TBL] [Abstract][Full Text] [Related]
2. Memory-like NK cells armed with a neoepitope-specific CAR exhibit potent activity against NPM1 mutated acute myeloid leukemia.
Dong H; Ham JD; Hu G; Xie G; Vergara J; Liang Y; Ali A; Tarannum M; Donner H; Baginska J; Abdulhamid Y; Dinh K; Soiffer RJ; Ritz J; Glimcher LH; Chen J; Romee R
Proc Natl Acad Sci U S A; 2022 Jun; 119(25):e2122379119. PubMed ID: 35696582
[TBL] [Abstract][Full Text] [Related]
3. Preactivation with IL-12, IL-15, and IL-18 induces CD25 and a functional high-affinity IL-2 receptor on human cytokine-induced memory-like natural killer cells.
Leong JW; Chase JM; Romee R; Schneider SE; Sullivan RP; Cooper MA; Fehniger TA
Biol Blood Marrow Transplant; 2014 Apr; 20(4):463-73. PubMed ID: 24434782
[TBL] [Abstract][Full Text] [Related]
4. Cytokine-Induced Memory-Like NK Cells: Emerging strategy for AML immunotherapy.
Bakhtiyaridovvombaygi M; Yazdanparast S; Mikanik F; Izadpanah A; Parkhideh S; Shahbaz Ghasabeh A; Roshandel E; Hajifathali A; Gharehbaghian A
Biomed Pharmacother; 2023 Dec; 168():115718. PubMed ID: 37857247
[TBL] [Abstract][Full Text] [Related]
5. Implication of Interleukin-12/15/18 and Ruxolitinib in the Phenotype, Proliferation, and Polyfunctionality of Human Cytokine-Preactivated Natural Killer Cells.
Terrén I; Mikelez I; Odriozola I; Gredilla A; González J; Orrantia A; Vitallé J; Zenarruzabeitia O; Borrego F
Front Immunol; 2018; 9():737. PubMed ID: 29713323
[TBL] [Abstract][Full Text] [Related]
6. iRGD-modified memory-like NK cells exhibit potent responses to hepatocellular carcinoma.
Dong Y; Huang Y; Zhang Z; Chen A; Li L; Tian M; Shen J; Shao J
J Transl Med; 2023 Mar; 21(1):205. PubMed ID: 36932395
[TBL] [Abstract][Full Text] [Related]
7. Cytokine-induced memory-like natural killer cells have enhanced function, proliferation, and in vivo expansion against ovarian cancer cells.
Uppendahl LD; Felices M; Bendzick L; Ryan C; Kodal B; Hinderlie P; Boylan KLM; Skubitz APN; Miller JS; Geller MA
Gynecol Oncol; 2019 Apr; 153(1):149-157. PubMed ID: 30658847
[TBL] [Abstract][Full Text] [Related]
8. Enhanced expression of natural cytotoxicity receptors on cytokine-induced memory-like natural killer cells correlates with effector function.
Carreira-Santos S; López-Sejas N; González-Sánchez M; Sánchez-Hernández E; Pera A; Hassouneh F; Durán E; Solana R; Casado JG; Tarazona R
Front Immunol; 2023; 14():1256404. PubMed ID: 37908353
[TBL] [Abstract][Full Text] [Related]
9. Semaphorin 7A modulates cytokine-induced memory-like responses by human natural killer cells.
Ghofrani J; Lucar O; Dugan H; Reeves RK; Jost S
Eur J Immunol; 2019 Aug; 49(8):1153-1166. PubMed ID: 31016720
[TBL] [Abstract][Full Text] [Related]
10. Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia.
Romee R; Rosario M; Berrien-Elliott MM; Wagner JA; Jewell BA; Schappe T; Leong JW; Abdel-Latif S; Schneider SE; Willey S; Neal CC; Yu L; Oh ST; Lee YS; Mulder A; Claas F; Cooper MA; Fehniger TA
Sci Transl Med; 2016 Sep; 8(357):357ra123. PubMed ID: 27655849
[TBL] [Abstract][Full Text] [Related]
11. Human Cytokine-Induced Memory-Like Natural Killer Cells.
Berrien-Elliott MM; Wagner JA; Fehniger TA
J Innate Immun; 2015; 7(6):563-71. PubMed ID: 25924651
[TBL] [Abstract][Full Text] [Related]
12. Cytokine-induced memory-like natural killer cells for cancer immunotherapy.
Tarannum M; Romee R
Stem Cell Res Ther; 2021 Dec; 12(1):592. PubMed ID: 34863287
[TBL] [Abstract][Full Text] [Related]
13. Natural killer (NK) cell-based immunotherapies and the many faces of NK cell memory: A look into how nanoparticles enhance NK cell activity.
Mikelez-Alonso I; Magadán S; González-Fernández Á; Borrego F
Adv Drug Deliv Rev; 2021 Sep; 176():113860. PubMed ID: 34237404
[TBL] [Abstract][Full Text] [Related]
14. IL-12/15/18-induced cell death and mitochondrial dynamics of human NK cells.
Terrén I; Sandá V; Amarilla-Irusta A; Lopez-Pardo A; Sevilla A; Astarloa-Pando G; Amo L; Zenarruzabeitia O; Scorrano L; Borrego F
Front Immunol; 2023; 14():1211839. PubMed ID: 37575238
[TBL] [Abstract][Full Text] [Related]
15. Optimizing NK Cell-Based Immunotherapy in Myeloid Leukemia: Abrogating an Immunosuppressive Microenvironment.
Kaweme NM; Zhou F
Front Immunol; 2021; 12():683381. PubMed ID: 34220833
[TBL] [Abstract][Full Text] [Related]
16. Optimized flow cytometry panel for the detection and analysis of human tumor-induced memory-like NK cells.
Schwab L; Bühler S; Biedritzky A; Schmidt M; Andre MC
J Immunol Methods; 2023 Apr; 515():113439. PubMed ID: 36758895
[TBL] [Abstract][Full Text] [Related]
17. Attenuated Cytokine-Induced Memory-Like Natural Killer Cell Responses to
Liang C; Li S; Yuan J; Song Y; Ren W; Wang W; Shang Y; Tang S; Pang Y
Infect Drug Resist; 2023; 16():2349-2364. PubMed ID: 37101462
[TBL] [Abstract][Full Text] [Related]
18. Utilizing cytokines to function-enable human NK cells for the immunotherapy of cancer.
Romee R; Leong JW; Fehniger TA
Scientifica (Cairo); 2014; 2014():205796. PubMed ID: 25054077
[TBL] [Abstract][Full Text] [Related]
19. Hematopoietic cell transplantation donor-derived memory-like NK cells functionally persist after transfer into patients with leukemia.
Berrien-Elliott MM; Foltz JA; Russler-Germain DA; Neal CC; Tran J; Gang M; Wong P; Fisk B; Cubitt CC; Marin ND; Zhou AY; Jacobs MT; Foster M; Schappe T; McClain E; Kersting-Schadek S; Desai S; Pence P; Becker-Hapak M; Eisele J; Mosior M; Marsala L; Griffith OL; Griffith M; Khan SM; Spencer DH; DiPersio JF; Romee R; Uy GL; Abboud CN; Ghobadi A; Westervelt P; Stockerl-Goldstein K; Schroeder MA; Wan F; Lie WR; Soon-Shiong P; Petti AA; Cashen AF; Fehniger TA
Sci Transl Med; 2022 Feb; 14(633):eabm1375. PubMed ID: 35196021
[TBL] [Abstract][Full Text] [Related]
20. Memory-like natural killer cells for cancer immunotherapy.
Gang M; Wong P; Berrien-Elliott MM; Fehniger TA
Semin Hematol; 2020 Oct; 57(4):185-193. PubMed ID: 33256911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
